[为慢性阻塞性肺病患者提供医疗支持的预计支出]
S A Linnik1,2, E E Tumenko1,2, S N Avdeev3
1N. A. Semashko National Research Institute of Public Health, 105064, Moscow, Russia.
Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny
|November 14, 2025
概括
计算慢性阻塞性肺病 (COPD) 患者的药物费用显示,标准护理和原始方法之间的结果相似,从234亿卢布到252亿卢布不等.
科学领域:
- 肺部病理学 肺部病理学
- 卫生经济学 卫生经济学
- 药物经济学 药物经济学
背景情况:
- 慢性阻塞性肺病 (COPD) 是一个重大的公共卫生挑战.
- 准确的成本评估对于有效的医疗保健规划和资源分配至关重要.
- 计算药物支持成本的现有方法可能有所不同,需要进行比较分析.
研究的目的:
- 计算为慢性阻塞性肺病 (COPD) 患者的药物支持所需的财政资源.
- 为了比较从标准医疗护理指南中得出的药物费用与原始计算方法.
- 为了确定哪些患者群体和药理学类代表了COPD的最高药物开支.
主要方法:
- 适用已确立的COPD患者医疗护理标准.
- 使用一种原创的方法来计算药物支持成本.
- 根据药理类和患者严重程度组 (C和D) 计算必要的药物总额.
主要成果:
- 对于COPD患者的药物支持的计算成本在标准方法和原始方法之间是可比的,差异不到10%.
- 总估计成本在234亿卢布至252亿卢布之间.
- 代表COPD更严重阶段的患者组C和D,承担了最大的药物费用.
结论:
- 该研究通过使用不同的方法验证了COPD药物支持成本计算的可比性.
- 调查结果为肺病学医疗保健规划和国家COPD倡议的制定提供了必要的数据.
- 对COPD治疗的资源分配应优先考虑疾病严重程度较高的患者群体,以确保足够的药物支持.
相关概念视频
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
01:22Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.0K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.0K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
01:26COPD: Management Using Bronchodilators and Corticosteroids
709
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
709